Cancer and its treatments can cause weight gain through several different mechanisms

Weight gain during cancer treatment is common and often unexpected. Unlike the weight loss many people associate with cancer, some patients and survivors gain pounds—sometimes significant amounts—during or after their illness. This happens because cancer itself, the drugs used to treat it, hormonal changes from treatment, and shifts in physical activity and eating patterns all work together to change how your body stores weight.

The weight gain is not simply about eating more. It reflects real changes in metabolism, appetite regulation, and body composition that happen as a direct result of cancer treatment. Understanding why this occurs helps explain why standard weight loss advice often does not work for cancer survivors, and why the weight can be stubborn to lose.

Key Takeaways

  • Certain cancer drugs—particularly some chemotherapy agents and hormonal therapies—directly increase appetite and cause the body to retain fluid and build fat tissue.
  • Corticosteroids given alongside chemotherapy to manage side effects are a major driver of weight gain and can increase appetite significantly.
  • Cancer treatment often reduces physical activity at the moment when metabolism is already slowing, creating a mismatch between calories burned and consumed.
  • Hormonal changes from treatments like tamoxifen or aromatase inhibitors can shift where the body stores fat and slow metabolic rate.
  • Weight gained during treatment tends to be harder to lose than weight from other causes because it involves changes to appetite hormones and metabolic rate, not just calorie imbalance.

How chemotherapy drugs affect weight and appetite

Some chemotherapy agents directly increase appetite and cause weight gain as a side effect. Drugs in the alkylating agent class (including cyclophosphamide) and certain other chemotherapy drugs trigger changes in the hormones that regulate hunger and fullness. Patients on these drugs often report feeling hungrier than they did before treatment, and that hunger does not diminish when they eat—a signal that the brain's appetite control has been altered, not that the body actually needs more calories.

Beyond appetite, some chemotherapy drugs cause the body to retain fluid, which shows up on the scale as weight gain but is not fat tissue. This fluid retention can be significant and may persist for weeks after treatment ends. Additionally, certain chemotherapy agents slow metabolism—the rate at which your body burns calories at rest—making it easier to gain weight even without eating more.

The role of corticosteroids in treatment-related weight gain

Corticosteroids like prednisone or dexamethasone are given alongside many chemotherapy regimens to prevent nausea, allergic reactions, and inflammation. These drugs are potent appetite stimulants and also cause the body to preferentially store fat in the face, neck, and upper back rather than distributing it evenly. Patients often notice this distinctive pattern of weight gain and describe feeling constantly hungry while on steroids.

The appetite increase from corticosteroids is not a matter of willpower or discipline—it is a direct pharmacological effect. The drug changes how your brain interprets hunger signals. Even small doses of steroids taken over weeks can produce noticeable weight gain. Once the steroid is stopped, appetite returns to normal, but the weight gained does not automatically disappear.

Hormonal therapies and changes in metabolism

Breast cancer survivors taking hormonal therapies like tamoxifen or aromatase inhibitors (letrozole, anastrozole, exemestane) frequently gain weight, sometimes 5 to 10 pounds or more over the course of treatment. These drugs work by blocking estrogen, which plays a role in regulating body weight and where fat is stored. When estrogen signaling is reduced, metabolism slows and the body becomes more efficient at storing fat.

Aromatase inhibitors appear to cause more weight gain than tamoxifen in most studies. The weight gain typically develops gradually over months rather than appearing suddenly, and it tends to accumulate in the abdomen. This shift in where fat is stored—toward visceral fat around the organs—is particularly relevant because abdominal fat carries different health risks than fat stored elsewhere.

Reduced activity and deconditioning during treatment

Cancer treatment is physically demanding. Chemotherapy causes fatigue that can last for weeks after each infusion. Radiation therapy causes localized fatigue and sometimes pain that limits movement. Surgery requires recovery time. During this period when patients are least active, their metabolism is often slowed by treatment drugs, creating a situation where calorie expenditure drops significantly while appetite may be increased.

Even after active treatment ends, many survivors remain less active than they were before cancer. Fear of recurrence, lingering fatigue, joint pain from certain drugs, or simply the disruption to normal routines can keep activity levels low. When activity stays reduced but appetite normalizes and metabolism partially recovers, the body is primed to gain weight.

Changes in taste, food preferences, and eating patterns

Cancer treatment alters taste perception in ways that can last months. Foods taste metallic, bitter, or unpleasantly strong. Patients often find that the foods they can tolerate are high-calorie comfort foods—ice cream, pudding, soup, pasta—because these are bland enough to eat without triggering nausea. Over weeks of treatment, eating patterns shift toward these calorie-dense options, and the habit can persist after taste returns to normal.

Additionally, some patients use food as a coping mechanism during a stressful and frightening time. Eating becomes one of the few pleasures available during treatment, or a way to regain a sense of control. These psychological patterns around food do not automatically reverse when treatment ends.

Why cancer-related weight gain is difficult to lose

Weight gained during cancer treatment is often harder to lose than weight from other causes because it involves changes to appetite hormones and metabolic rate, not just a simple calorie surplus. A person who gained 15 pounds by eating more during a normal year might lose it by returning to their previous eating habits. A cancer survivor who gained 15 pounds during chemotherapy may find that their appetite hormones remain altered, their metabolism stays somewhat slower, and their body resists losing the weight even with diet and exercise changes.

This is why standard weight loss approaches—eat less, move more—often produce disappointing results for cancer survivors. The underlying physiology has changed. Some research suggests that weight gained during chemotherapy, particularly with certain drug combinations, may involve changes to how fat cells function and how the body regulates energy storage. These changes can take months or years to fully reverse, if they do at all.

Frequently Asked Questions

Does weight gain during cancer treatment mean the cancer is getting worse?

No. Weight gain during treatment is a side effect of the drugs and the treatment process itself, not a sign that cancer is progressing. In fact, some weight gain during chemotherapy can be a sign that the treatment is strong enough to cause significant side effects. Weight loss during cancer, by contrast, can sometimes indicate that the cancer is consuming resources or that the body is not tolerating treatment well.

Will the weight come off once treatment is finished?

Some of it may, particularly fluid retention, which can resolve within weeks of stopping certain drugs. However, weight gained from increased appetite, slowed metabolism, and reduced activity often persists. Many survivors find that weight loss after treatment requires more effort than it did before cancer, and some weight may remain permanently unless addressed through diet and activity changes specifically designed for post-treatment recovery.

Can I diet while undergoing cancer treatment?

Restrictive dieting during active cancer treatment is generally not recommended because your body needs adequate nutrition to tolerate treatment and recover between sessions. Discussing nutrition with your oncology team or a registered dietitian who specializes in cancer care is important—they can suggest ways to manage appetite and food choices without compromising your ability to complete treatment safely.

Does weight gain happen with all cancer treatments?

No. Some chemotherapy drugs are more likely to cause weight gain than others. Hormonal therapies cause weight gain in many but not all patients. Radiation therapy and surgery alone are less likely to cause significant weight gain, though reduced activity during recovery can contribute. Your specific treatment plan and individual response determine whether weight gain is likely.

Is the weight gain from cancer treatment just water weight?

Some of it is. Corticosteroids and certain chemotherapy drugs cause fluid retention. However, much of the weight gain is actual fat tissue, not just fluid. The appetite-stimulating effects of treatment drugs and the reduction in physical activity lead to genuine increases in body fat, not just temporary swelling. This is why the weight does not disappear once the drugs are stopped.